Online tumor conference in the clinical management of gynecological cancer: experience from a pilot study in Germany

…, A Suesse, A Widing, B Ruhmland… - International Journal of …, 2008 - ijgc.bmj.com
The concept of the online tumor conference was established in 2004 as a pilot project. We
developed specific web-based software to organize and conduct online tumor board …

Efficacy and safety of trastuzumab plus capecitabine in a German multicentre phase II study of pre-treated metastatic breast cancer

…, HJ Hindenburg, P Klare, B Ruhmland… - Journal of Clinical …, 2005 - ascopubs.org
717 Background: Trastuzumab (Herceptin; H) in combination with a taxane has proven
significant clinical benefits, including a survival advantage, compared with taxane alone in …

[HTML][HTML] A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis

…, H Sommer, P Klare, A Belau, B Ruhmland… - Journal of cancer …, 2012 - Springer
Background Treosulfan, an alkylating agent, has demonstrated activity in recurrent ovarian
carcinoma. It is equieffective as oral (po) and intravenous (iv) formulation. To explore the …

Effect of fetal umbilical cord entanglement on the postnatal status of the newborn infant

M David, B Ruhmland - Zentralblatt fur Gynakologie, 1995 - europepmc.org
The incidence of umbilical cord entanglements is about 30-35%. Their role for the fetal
outcome and the obstetrical management (in case the entanglement has been detected …

A case of septic ovarian vein thrombosis

B Ruhmland, H Reiher, H Randow - Zentralblatt fur Gynakologie, 1990 - europepmc.org
Puerperal ovarian vein thrombosis commonly originates from purulent necrotic
endomyometritis. The incidence is published to be 1 to 600 deliveries. According to the …

Interdisciplinary Online Tumorconference: Implementation of a new tool in the management of gynaecological cancers in Germany

…, A Süße, P Klare, B Ruhmland… - Geburtshilfe und …, 2006 - thieme-connect.com
Objectives: The clinical management in the gynaecologic oncology have gained large
changes in the last years. International guidelines and new study results have to be …

Endokrine Therapielandschaft bei prämenopausalen Patientinnen mit HR+ HER2-frühem Mammakarzinom vor Einführung der CDK4/6-Inhibitor-Behandlung in …

…, C Grossmann, J Ebert, B Ruhmland… - Senologie-Zeitschrift …, 2023 - thieme-connect.com
Zielsetzung Bisherige Daten zeigen bei prämenopausalen Frauen mit HR+, HER2-frühem
Mammakarzinom und höherem Rezidivrisiko Überlebensvorteile einer Therapie mit …

[CITATION][C] Detecting psychosocial needs in ambulatory cancer patients during chemotherapy

J Heymanns, F Breuer, HF Hinrichs, B Ruhmland… - J Cancer Res Clin Oncol, 2000

[CITATION][C] Capecitabine and trastuzumab: a phase II study in HER2-overexpressing metastatic breast cancer (MBC) patients pretreated with anthracyclines and/or …

…, HJ Hindenburg, B Ruhmland… - BREAST …, 2005 - SPRINGER 233 SPRING STREET …

[CITATION][C] The influence of twisted fetal umbilical cord on the fetal outcoume

M David, B Ruhmland - Zentralblatt fur Gynakologie, 1995 - Leipzig.